Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19806928 | 0.98 | TYR (0.52) | TYR | |
| SCHEMBL3793824 | 0.95 | TYR (0.50) | TYRESR1PDCD1ESR2CD274 | |
| SCHEMBL19806923 | 0.91 | TYR (0.47) | TYRESR1ESR2 | |
| SCHEMBL19806855 | 0.88 | TYR (0.49) | TYR | |
| SCHEMBL19806929 | 0.88 | ALOX15 (0.44) | TYRESR1ESR2ALDH1A1GAA | |
| SCHEMBL19806857 | 0.88 | TYR (0.53) | TYRESR1PDCD1ESR2CD274 | |
| SCHEMBL84243 | 0.87 | TYR (0.67) | TYRALDH1A1GAAKMT2ATDP1 | |
| SCHEMBL28642768 | 0.85 | TYR (0.52) | TYRESR1 | |
| SCHEMBL19806864 | 0.85 | TYR (0.54) | TYRESR1ESR2ALDH1A1GAA | |
| SCHEMBL19806852 | 0.83 | TYR (0.45) | TYRESR1ESR2ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210070685-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20210070683-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-03-11 | — | — | US | disclosed |
| WO-2018016640-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, AND CIRCUIT PATTERN FORMATION METHOD | 三菱瓦斯化学株式会社 | 2018-01-25 | — | — | WO | disclosed |
| US-5532107-A | Positive resist composition | NIPPON ZEON CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| EP-0430477-B1 | Positive resist composition | NIPPON ZEON CO (JP) | 1996-05-22 | — | — | EP | disclosed |
| US-5306596-A | Positive resist composition comprising a polyphenolic o-quinone diazide sulfonate | NIPPON ZEON CO., LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070683-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | RER1, RTN4, FEM1B | TYR 3769/4885ESR1 1539/4885PDCD1 4778/4885 |
| US-20210070685-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | RER1, RTN4, FEM1B | TYR 3769/4885ESR1 1539/4885PDCD1 4778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.